Resveratrol did not prevent sevoflurane-induced neuroapoptosis in the neonatal mice brain

Japanese Journal of Anesthesiology

Volumn 62, Issue 10, 2013, Pages 1184-1187

  Satomoto, Maiko ^a   Itoh, Hiroyuki ^a   Uchida, Atsujiro ^a   Makita, Koshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Anesthesia; Developing brain; Neuroapotosis; Resveratrol; Sevoflurane

Indexed keywords

CASPASE 3; POLY(ADENOSINE DIPHOSPHATE RIBOSE); RESVERATROL; SEVOFLURANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL NECROSIS; NEUROAPOPTOSIS; NEUROPROTECTION; NEWBORN; NONHUMAN; PRENATAL DRUG EXPOSURE; PUP (RODENT); WESTERN BLOTTING;

ANESTHETICS, INHALATION; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; APOPTOSIS; BRAIN; METHYL ETHERS; MICE; MICE, INBRED C57BL; STILBENES;

EID: 84886732006     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wilder RT, Flick RP Sprung J, Katusic SK, Barbaresi WJ, Mickelson C, et al. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009; 110 : 796-804.
2. Kalkman CJ, Peelen L, Moons KG, Veenhuizen M, Bruens M, Sinnema G, et al. Behavior and development in children and age at the time of first anesthetic exposure. Anesthesiology 2009; 110 : 805-12.
3. DiMaggio C, Sun LS, Li G. Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort. Anesth Analg 2011; 113 : 1143-51.
4. Hansen TG, Pedersen JK, Henneberg SW, Pedersen DA, Murray JC, Morton NS, et al. Academic performance in adolescence after inguinal hernia repair in infancy : A nationwide cohort study. Anesthesiology 2011; 114 : 1076-85.
5. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosa 2003; 23 : 876-82.
6. Fredriksson A, Pontén E, Gordh T, Eriksson P. Neonatal exposure to a combination of N-methyl-D-aspartate and -aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neuro-degeneration and persistent behavioral deficits. Anesthesiology 2007; 107 : 427-36.
7. Johnson SA, Young C, Olney JW. Isoflurane-induced neuroapoptosis in the developing brain of nonhypoglycemic mice. J Neurosurg Anesthesiol 2008; 20 : 21-8.
8. Satomoto M, Satoh Y, Terui K, Miyao H, Takishima K, Ito M, et al. Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology 2009; 110 : 628-37.
9. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444 : 337-42.
10. Rimbaud S, Ruiz M, Piquereau J, Mateo P, Fortin D, Veksler V, et al. Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS One 2011; 6 : e26391.
11. Tiwari V, Chopra K. Resveratrol prevents alcohol-induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain. J Neurochem 2011; 117 : 678-90.
12. Wong RH, Howe PR, Buckley JD, Coates AM, Kunz I, Berry NM. Acute resveratrol supplementation improves flow-mediated dilatation in over-weight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis 2011; 21 : 851-6.
13. Kennedy DO, Wightman EL, Reay JL, Lietz G, Okello EJ, Wilde A, et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans : A double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 2010; 91 : 1590-7.
14. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers : Safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 2010; 70 : 9003-11.